Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

21. Mars 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2973


	Articles 1 - 20 / 59454

	mRNA-based cancer vaccines: A new frontier in personalized immunotherapy. Biochim Biophys Acta Rev Cancer Garg P, Salgia R, Singhal SS. PMID: 41861922 [PubMed - as supplied by publisher]
	Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). Int J Oncol Aloliqi AA, Alnuqaydan AM, Alshebremi M, Rahmani AH, Khan AA. PMID: 41860028 [PubMed - indexed for MEDLINE]
	Pediatric Solid Pseudopapillary Neoplasm With Aberrant CD31 Expression: A Potential Diagnostic Pitfall. Cureus Nazer J, Vallonthaiel AG, Yesodharan J, Viswanath N. PMID: 41859616 [PubMed]
	Evaluating large language models for automated TNM staging from PET-CT reports: a multi-cancer comparative study. Front Digit Health Xu W, Cao L, Shen Q, Shan Y, Pan S, Ruan M. PMID: 41858507 [PubMed]
	Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours. J Neuroendocrinol Partelli S, Bartsch DK, Falconi M, Grossman A, Knigge U, Langer SW, Martin W, O'Toole D, Perren A, Schrader J, Stalberg P, Walter T, Janson ET. PMID: 41856794 [PubMed - indexed for MEDLINE]
	The Hallmarks of Pancreatic Cancer. Cancer Lett Kane LE, Hackett D, Lyons R, Ryan BM, Maher SG. PMID: 41856311 [PubMed - as supplied by publisher]
	Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions. Int Immunopharmacol Liu X, Fan X, Wang Y, Wang L, Lu D, Wang Y, Meng X, Fan L, Zhu W, Liu X, Ye L, Sun P. PMID: 41855774 [PubMed - as supplied by publisher]
	Extracellular RNAs in pancreatic cancer: from pathogenesis to precision medicine. Expert Opin Biol Ther Rezazadeh M, Aghakhani A, Bahreini F, Rezaei N. PMID: 41855510 [PubMed - as supplied by publisher]
	Explainable artificial intelligence for personalized prognosis in pancreatic cancer: A nationwide study from Taiwan. PLOS Digit Health Tsai DR, Chiang CJ, Hsieh PC, Huang CY, Lee WC. PMID: 41855151 [PubMed]
	Diagnostic and surgical challenges of a lymph node metastasis from occult gastric cancer mimicking a pancreatic head tumor: A case report. Oncol Lett Ando T, Hirose Y, Takizawa K, Sakata J, Ishikawa H, Abe S, Kawachi Y, Nakano M, Ichikawa H, Shimada Y, Wakai T. PMID: 41852893 [PubMed]
	Differentiating Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma Using Computed Tomography. Can Assoc Radiol J Alkatheeri M, Barat M, Moyne T, Pellat A, Dohan A, Nguyen TTL, Bonnin A, Coriat R, Dautry R, Rouquette A, Marchese U, Soyer P. PMID: 41852046 [PubMed - as supplied by publisher]
	Pancreatic PEComa: Case Report of an Extremely Rare Tumor. Arch Iran Med Zinovkin D, Davydov DA, Kisialeu PG, Kolbik DA, Achinovich SL, Portyanko AS, Pranjol MZI. PMID: 41852007 [PubMed - indexed for MEDLINE]
	Stent Patency and Survival after PTBD and Biliary Stenting for Pancreatic Cancer: A 5-Year Retrospective Cohort Study. Arch Iran Med Tao Y, Tang J, Yu W, Yang W, Zhang M, Wu Q, Li J. PMID: 41852003 [PubMed - indexed for MEDLINE]
	Multi-omics analysis and experimental validation uncovers prognosis significance of IKBIP in patients with hepatocellular carcinoma: a multicenter cohort study. BMC Gastroenterol Jiao Y, Guo L, Lu Y, Li M, Zhong Y, Wu B, Dong H, Wang T, Chen E. PMID: 41851828 [PubMed - as supplied by publisher]
	The combination of a cancer vaccine, pembrolizumab, and stereotactic body radiation in patients with locally advanced pancreatic cancer: a single-arm, phase II study. Nat Commun Lee V, Sachidanand AS, Rodriguez C, Wang J, Onners B, Qi H, Parkinson R, McPhaul T, Durham J, Ding D, Hacker-Prietz A, Narang AK, Le DT, De Jesus A, Pishvaian M, Christenson E, Thompson ED, Anders RA, Osipov A, Weiss M, Burns W, Burkhart R, Lafaro K, He J, Wolfgang CL, Sugar E, Herman JM, Jaffee EM, Wang H, Laheru DA, Zheng L. PMID: 41851087 [PubMed - as supplied by publisher]
	Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumour-stroma ratio. Gut Huang HY, Wu K, Qu LM, Sun XD, Li MY, Wei F, Zhang P, Kow AWC, Chen YG, Jin MS, Guo L, Qiu W, Wang M, Shi XJ, Ye JF, Hu CH, Zhao YX, Huang Y, Fan ZQ, Zheng YS, Xie FY, Lv GY. PMID: 41850702 [PubMed - as supplied by publisher]
	Association of social determinants of health diagnosis codes with overall survival in Medicare-insured patients with cancer. J Natl Cancer Inst Herb JN, Hu CY, Giordano SH, Chang GJ, Snyder RA. PMID: 41849418 [PubMed - as supplied by publisher]
	Factors affecting compliance with pancreas surveillance in patients with familial/genetic risk. Fam Cancer Abou Sleiman E, Sinan H, Shin EJ, Canto MI, Goggins M. PMID: 41848926 [PubMed - indexed for MEDLINE]
	SIMBA-a Bayesian decision framework for the identification of optimal biomarker subgroups for cancer basket clinical trials. Biometrics Yuan S, Liu J, Gong Z, Qin X, Qin C, Ji Y, Müller P. PMID: 41847799 [PubMed - indexed for MEDLINE]
	Minimally invasive surgery for remnant gastric cancer: a single-center retrospective study of treatment outcomes in Japan. J Minim Invasive Surg Iwasaki K, Barroga E, Kaneko Y, Kondo S, Sakurai T, Yamada E, Enomoto M, Shimoda Y, Kasahara K, Osakabe H, Mazaki J, Kuwabara H, Oguma J, Koga H, Kanazawa A, Nakagawa Y. PMID: 41847786 [PubMed]

Articles 1 - 20 / 59454

Page 1 de 2973



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité